Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting from Altered Gravity Levels

The effect of altered gravity on astronauts' perceptions and motor skills is significant as it threatens the health, well-being, and performance of crews. Astronauts experience gravitational transitions from Earth's gravitational level during launch to microgravity in space, then to partial gravity if landing on the Moon, Mars, or Martian moons, followed by a return to microgravity, and finally re-entry back to Earth. In addition, the use of Artificial Gravity (AG) from an on-board centrifuge also presents an altered gravity challenge, in particular during transitions between gravity levels. During each of these g-transitions astronauts must adapt their sensorimotor programs to coordinate perceptual and motor capabilities and function successfully and safely. The ability to identify and predict changes in sensorimotor function during these g-transitions is essential to the development of protocols and countermeasure implementation for future crew members. This project takes a new approach which could lead to a practical and acceptable protocol. We alter gravito-inertial accelerations with centrifugation in different body orientations. Furthermore, we have quantified sensory adaptation capabilities of both perception and manual control ability to a transition into hypo-gravity. Additionally, we investigated the effect of a common motion sickness drug, promethazine, on basic vestibular motion perception. This is an important step in better understanding the benefits and risks associated with the use of motion sickness drugs in conjunction with adaptation training and in flight after critical gravity transitions.

Specific Aims: The original specific aims for this project were: SA1) Demonstrate that individual differences exist in the ability to adapt to gravitational transitions, and can be measured quantitatively by measures of subjective orientation, closed loop manual control, and subjective motions sickness reports. SA2) Test whether pre-training by adapting to one altered gravity environment can improve sensorimotor adaptation in another altered gravity environment. SA3) Test whether the leading pharmacological agent, promethazine, affects either basic vestibular perceptual function or the adaptation rate to an altered gravity environment and the associated motion sickness symptoms. SA4) Develop and test a combined pre-adaptation training and pharmacological intervention protocol that can both improve sensorimotor adaptation and reduce the associated motion sickness.

Hypotheses: The hypotheses are: H1) Individual differences exist in the ability to adapt to altered gravity environments and these differences can be predicted by measuring adaptability in one altered gravity environment. H2) Pre-adaptation training in one altered gravity environment will improve sensorimotor adaptation in another altered gravity environment. H3) Promethazine will reduce motion sickness, but will have no influence on either basic vestibular perceptual function or sensorimotor adaptation to altered gravity environments.

Results: We determine individual differences in performance of both the perception and manual control tasks in terms of initial performance decrement and adaptation time constant. All subjects consistently show a performance decrement in the perception and closed-loop manual control task on initial exposure to altered-gravity, followed by a return back to baseline performance. Promethazine significantly affects upright roll tilt motion perception thresholds, a measure of basic vestibular perceptual function. Thresholds were not different with promethazine for upright yaw or upright interaural translation motions. However, the small but consistent effect of promethazine on roll tilt perception could have functional and operational significance.

Deliverables: Deliverables are a methodology for measuring an individual's capacity to adapt to an altered gravity environment using affordable centrifuge tests, and a combined pharmacological and pre-adaptation training intervention to reduce the severity of motion sickness and sensorimotor impairment during gravitational transitions.

More »